News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Vaxxinity, Inc.
Vaxxinity UB-312 Parkinson’s Trial Results Published in Nature Medicine
June 20, 2024
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity Issues Shareholder Letter
April 19, 2024
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock
April 19, 2024
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting
March 28, 2024
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates
March 27, 2024
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024
March 07, 2024
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published
February 15, 2024
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024
February 13, 2024
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida
January 30, 2024
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity Announces Collaboration on Space Medicine Research with University of Central Florida
January 18, 2024
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity to Present at the 2024 J.P. Morgan Healthcare Conference
January 03, 2024
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity to Present at Upcoming November Medical and Investor Conferences
November 13, 2023
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 08, 2023
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity to Present at Upcoming Investor Conferences in September
August 29, 2023
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity Announces Publication of UB-311 Safety, Tolerability, Immunogenicity, and Clinical Efficacy Data from Phase 2a Trial in Alzheimer’s Disease
August 10, 2023
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 09, 2023
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity Appoints Peter Powchik, M.D., to Executive Vice President, Global Scientific Director
July 27, 2023
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity Demonstrates Target Engagement of Toxic Alpha-Synuclein in Parkinson’s Patients
July 17, 2023
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity Announces UB-312 Successfully Met Primary Objectives of Phase 1 Clinical Trial in Parkinson’s Disease
June 22, 2023
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 09, 2023
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity to Present at World Vaccine Congress, American Academy of Neurology, and BNA2023 Festival of Neuroscience in April
March 28, 2023
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Updates
March 27, 2023
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity Joins TransCelerate Research and Development Consortium
March 21, 2023
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity Announces First Subjects Dosed in Phase 1 Clinical Trial of VXX-401, Investigational Anti-PCSK9 Vaccine to Treat Hypercholesterolemia
March 20, 2023
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity to Present at Upcoming March Scientific and Medical Conferences
March 02, 2023
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity Announces Board Appointments and Establishes New Headquarters in Florida
February 01, 2023
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity to Present at the 2023 J.P. Morgan Healthcare Conference
January 05, 2023
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity Announces Positive Topline Pivotal Phase 3 COVID-19 Booster Data for UB-612
December 02, 2022
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 10, 2022
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Vaxxinity to Host First Analyst and R&D Day in New York City on November 10, 2022
November 03, 2022
From
Vaxxinity, Inc.
Via
GlobeNewswire
Tickers
VAXX
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.